Platelet-activating factor-induced contraction of human isolated bronchus

Area of Science:

• Pulmonary Medicine
• Immunology
• Pharmacology

Background:

• Platelet-activating factor (PAF) is implicated in asthma, causing bronchoconstriction in non-asthmatic individuals.
• The precise mechanism behind PAF-induced bronchoconstriction and its variability remains unclear.
• Previous research indicates variable contractile responses of human bronchi to PAF.

Purpose of the Study:

• To investigate if variable contractile responses to PAF in human isolated bronchi are due to mediator release from inflammatory or epithelial cells.
• To examine the relationship between PAF-induced contractions and the presence/number of specific inflammatory cells and intact epithelium.

Main Methods:

• Studied eight human bronchial tissue samples from five patients.
• Assessed isometric tone changes in vitro to measure contractile responses to PAF (7 x 10(-7) M).
• Quantified inflammatory cell counts (eosinophils, neutrophils, lymphocytes, plasma cells) and percentage of intact epithelium via histology.

Main Results:

• Four of eight tissues contracted in response to PAF, while four did not.
• No significant correlation was found between the magnitude of PAF-induced contraction and the numbers of eosinophils, neutrophils, lymphocytes, plasma cells, total cells, or percentage of intact epithelium.
• The variability in contractile responses did not correlate with the presence or quantity of inflammatory cells or epithelium.

Conclusions:

• Variability in human airway response to PAF is unlikely to be mediated by the release of secondary mediators from inflammatory or epithelial cells.
• The observed variability in contraction magnitude is probably not linked to the number of inflammatory cells or the presence of epithelium.
• Further research is needed to elucidate the exact mechanisms underlying PAF-induced bronchoconstriction variability.